Țară: Grecia
Limbă: engleză
Sursă: HMA (Heads of Medicines Agencies)
lincomycin 110 mg/g
Lavet Pharmaceuticals Ltd.
QJ01FF02
Premix for medicated feed
lincomycin
Pigs
2010-11-24
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Linco-Feed 110 mg/g premix for medicated feeding stuff for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each g product contains: ACTIVE SUBSTANCE: Lincomycin (as hydrochloride) 110 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Premix for medicated feeding stuff. White or almost white granules. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Swine. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For treatment of swine dysentery caused by_ Brachyspira hyodysenteriae, _mycoplasmal pneumonia associated with _Mycoplasma hyopneumoniae _and porcine proliferative enteropathy (ileitis) associated with _Lawsonia intracellularis_. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipient. Do not use in horses, ruminants, rabbits, guinea pigs and hamsters. Do not use if resistance to lincosamides has been detected. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Inappropriate use of the product may increase the prevalence of bacteria resistant to lincosamides. Use of the product should be _based on susceptibility testing_ and take into account official and local _antimicrobial policies_. The presence of the indicated diseases in the herd should be established before use. 4.5 SPECIAL PRECAUTIONS FOR USE _Special precautions for use in animals _ Medicated feeding stuff uptake can be affected by the severity of the disease. In case of insufficient uptake of feed, animals should be treated parenterally. _Special precautions to be taken by the person administering the veterinary medicinal product Citiți documentul complet